Mercer Global Advisors
CRMD icon

Mercer Global Advisors’s CorMedix CRMD Stock Holding History

Mercer Global Advisors’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$86K Buy
+12,667
New +$93.6K ﹤0.01% 3053

Other funds holding CRMD

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Mercer Global Advisors's CRMD Position: Q1 2026 in Review

Mercer Global Advisors opened a new position in CorMedix (CRMD) in Q1 2026: 12,667 shares worth $86K. The stake represents ﹤0.01% of the portfolio and ranks #3053 among its holdings.

187 funds tracked by Wall St. Rank hold CRMD as of Q1 2026.

  • Mercer Global Advisors held 12,667 shares of CorMedix worth $86K as of Q1 2026.
  • CorMedix was a new Mercer Global Advisors position in Q1 2026.
  • CorMedix made up ﹤0.01% of Mercer Global Advisors's portfolio in Q1 2026, its #3053 holding.
  • 187 funds tracked by Wall St. Rank held CorMedix as of Q1 2026.

Based on Mercer Global Advisors's 13F filing for Q1 2026, filed 15 May 2026.